17. Dec 2019

WDF receives grant to support refugees and host communities in Jordan

Bent Lautrup-Nielsen
The WDF will support prevention and treatment of diabetes, high blood pressure and other NCDs among Syrian refugees and vulnerable host communities in Jordan.

BAGSVÆRD, DENMARK 17 Dec 2019 - 

The World Diabetes Foundation has received a DKK 25 million grant approval from the Novo Nordisk Foundation to support the fight against noncommunicable diseases (NCDs) in Jordan. 

The grant supports a project that will seek to implement an integrated NCD-humanitarian national response strategy with focus on prevention and access to care for both refugee populations and Jordanians. 

The goal is to reduce the burden of NCDs, especially diabetes and high blood pressure, among refugees and other vulnerable groups in Jordan.

“By providing support, we want to help to improve the living conditions and future prospects for the Syrian refugees in Jordan. We also want to help create global awareness of the challenges noncommunicable diseases present in humanitarian crises and highlight appropriate solutions for patients,” says Hanna Line Jakobsen, Head of Social and Humanitarian, Novo Nordisk Foundation.

Leif Fenger Jensen, Managing Director, World Diabetes Foundation, says: “The grant from the Novo Nordisk Foundation will enable an ambitious and essential effort to integrate both prevention and control of NCDs into Jordan’s humanitarian initiatives. We look forward to realising the initiatives in collaboration with the Government of Jordan and the Royal Health Awareness Society of Jordan, and in a framework consisting of many other national and international agencies and partners.”

Areas of intervention
The project will support activities within three main areas anchored in national health system planning and humanitarian response actions concerning health:

Prevention 
Various activities will be implemented to promote improved knowledge and practices related to NCD prevention, with emphasis on the globally defined and most common risk factors: unhealthy diet, lack of physical activity and smoking. Target groups will also include children and adolescents, and the use of social media and new digital health solutions will be explored.

Treatment
Primary health care services will be strengthened to improve access to care for people with NCDs focusing on diabetes and high blood pressure. More than 200 clinics will receive basic equipment, training of health care professionals, and improved patient record systems. Screening will be rolled out and treatment provided, both at clinics located within existing refugee camps and at clinics in host communities across Jordan.   

Policy and knowledge-sharing
The interventions will be embedded in policies and strategies seeking to integrate prevention and control of NCDs into Jordan’s overall humanitarian relief efforts. Comprehensive monitoring activities and implementation research will be part of the project to ensure documentation and allow dissemination of results and learnings to other settings in Middle East and beyond, where an integration of NCD responses into humanitarian programmes concerning health would be relevant.  

Increased support for humanitarian purposes
The grant is part of the Novo Nordisk Foundation’s new strategy for humanitarian and development grants. Read more here.
To WDF the grant will catalyse a strategy to support responses to diabetes and other NCDs in settings of humanitarian crises. WDF has been active in Jordan and the Middle East for more than a decade through partnerships with governments, national stakeholders and international agencies, and the new grant will significantly scale up the partnership with Jordan.

About the Novo Nordisk Foundation
The vision of the Foundation is to contribute significantly to research and development that improves the lives of people and the sustainability of society. Since 2010, the Foundation has awarded more than DKK 20 billion (€2.7 billion), primarily for research at public institutions and hospitals in Denmark and the other Nordic countries. www.novonordiskfoundation.com

About the World Diabetes Foundation
The World Diabetes Foundation is a leading global funder of diabetes prevention and care projects in the developing world. Our vision is to alleviate human suffering related to diabetes among those in greatest need. We pursue sustainable, scalable approaches, helping countries meet global goals for improved care of diabetes and other non-communicable diseases. 
Since 2002, the World Diabetes Foundation has provided 150 million USD in funding to 558 partnership projects in 116 countries. www.worlddiabetesfoundation.org


For more information please contact:

World Diabetes Foundation:
Bent Lautrup-Nielsen, Senior Advisor, 
+45 3075 0139, blpn@worlddiabetesfoundation.org

Novo Nordisk Foundation:
Christian Mostrup Scheel, Senior Press Officer, 
+45 3067 4805, cims@novo.dk

DOWNLOAD the press release